Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept study of oral Octreolin on hepatic venous pressure gradient in cirrhosis with portal hypertension
2010-023895-26Phase 2Completed
- Sponsor
- Chiasma
- Start
- Feb 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of octreotide in Portal Hypertension (PH) and Cirrhosis, sponsored by Chiasma. Primary endpoint: Effect of Octreolin on hepatic venous pressure gradient response. Started Feb 2011; status: completed.
02
Drugs
octreotide
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on 2010-023895-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023895-26.